Skip to main content

Harrow, Inc.

HROW
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001360214

In the last 90 days, Harrow, Inc. insiders filed 0 open-market purchases and 1 sale; 223 institutions reported holding it in 13F filings for Q2 2026, worth $912.6M in total; no superinvestor holds it.

Q2 2025 vs. Q1 2025

How the institutions holding Harrow, Inc. changed between Q1 2025 and Q2 2025.

All holders in Q2 2025All holders in Q1 2025

13F holders of HROW: Q1 2025 compared with Q2 2025
MeasureQ1 2025Q2 2025Change
Holders157161+4
Shares20.7M21.1M+332.5K (+1.6%)
Value$551.3M$643.3M+$92.0M (+16.7%)

New holders (29)

Institutions that held Harrow, Inc. at the end of Q2 2025 but not at the end of Q1 2025.

Sold out (25)

Institutions that held Harrow, Inc. at the end of Q1 2025 and filed for Q2 2025 without it.